When managing pediatric psoriasis patients who have achieved stable remission on systemic therapies, how do you approach tapering or stopping therapy?

A recent article on Medscape linked below conducted a multicenter study with their results regarding stopping treatment in the pediatric psoriasis patients on systemic therapy and found that, among patients who discontinued treatment because of remission, 88.6% remained off systemic treatment for at least 6 months. Does this study alter your clinical approach to attempting a trial of treatment cessation in your pediatric patients who have achieved clearance? https://www.medscape.com/viewarticle/can-children-stop-psoriasis-treatment-after-remission-2026a1000nin?ecd=a2a